COBENFY Trademark

Trademark Overview

On Monday, March 28, 2022, a trademark application was filed for COBENFY with the United States Patent and Trademark Office. The USPTO has given the COBENFY trademark a serial number of 97333525. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, June 27, 2024. This trademark is owned by Karuna Therapeutics, Inc.. The COBENFY trademark is filed in the Pharmaceutical Products category with the following description:

prescription medications for the treatment of neuropsychiatric disorders
cobenfy

General Information

Serial Number97333525
Word MarkCOBENFY
Filing DateMonday, March 28, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, June 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2022

Trademark Statements

Goods and Servicesprescription medications for the treatment of neuropsychiatric disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 1, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKaruna Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02110
Party NameKaruna Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02110

Trademark Events

Event DateEvent Description
Tuesday, May 24, 2022NON-FINAL ACTION E-MAILED
Thursday, March 31, 2022NEW APPLICATION ENTERED
Friday, April 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 24, 2022ASSIGNED TO EXAMINER
Tuesday, May 24, 2022NON-FINAL ACTION WRITTEN
Tuesday, May 24, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 15, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 29, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 29, 2023SOU EXTENSION 1 FILED
Thursday, June 29, 2023SOU EXTENSION 1 GRANTED
Saturday, July 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 2, 2024SOU EXTENSION 2 FILED
Tuesday, January 2, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 2, 2024SOU EXTENSION 2 GRANTED
Thursday, January 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 27, 2024SOU EXTENSION 3 GRANTED
Tuesday, September 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 27, 2024SOU EXTENSION 3 FILED
Thursday, June 27, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

cobenfy disorders neuropsychiatric treatment medications prescription